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Nucleus downscaling in mouse 
embryos is regulated by 
cooperative developmental and 
geometric programs
Elina Tsichlaki1 & Greg FitzHarris1,2,3
Maintaining appropriate nucleus size is important for cell health, but the mechanisms by which 
this is achieved are poorly understood. Controlling nucleus size is a particular challenge in early 
development, where the nucleus must downscale in size with progressive reductive cell divisions. Here 
we use live and fixed imaging, micromanipulation approaches, and small molecule analyses during 
preimplantation mouse development to probe the mechanisms by which nucleus size is determined. 
We find a close correlation between cell and nuclear size at any given developmental stage, and show 
that experimental cytoplasmic reduction can alter nuclear size, together indicating that cell size helps 
dictate nuclear proportions. Additionally, however, by creating embryos with over-sized blastomeres 
we present evidence of a developmental program that drives nuclear downscaling independently of 
cell size. We show that this developmental program does not correspond with nuclear import rates, but 
provide evidence that PKC activity may contribute to this mechanism. We propose a model in which 
nuclear size regulation during early development is a multi-mode process wherein nucleus size is set by 
cytoplasmic factors, and fine-tuned on a cell-by-cell basis according to cell size.
Establishment and regulation of sub-cellular architecture is a poorly understood aspect of development, and 
is a particular challenge as cells lessen in size during early embryogenesis. Perhaps the most obvious example 
of an organelle that must downscale its size during early development is the nucleus, but how this is achieved 
is unknown. Indeed, the mechanisms that dictate nuclear dimensions are poorly understood in any cellular 
system1–3. Establishing and controlling the correct nucleus size is important for cellular function, having a direct 
effect on the morphogenesis of organelles, homeostasis, and cell differentiation. Accordingly, alterations in 
nuclear size and shape are associated with disease states4–7, and maintaining nucleus size is crucial for develop-
ment8,9. Thus, regulatory mechanisms must operate that are capable of adapting nucleus size to cell type and then 
stringently regulating nucleus size to support cellular function during early development.
Recent studies have focused on two distinct but non mutually-exclusive models as to how nuclear size 
control might be achieved. First, within any given cell type the relative size of the nucleus within the cell (the 
nuclear/cytoplasmic ratio; N/C) remains constant8,10–14, implying that cytoplasmic volume determines nuclear 
size. However, direct evidence that cell size impacts nucleus size is scarce. Second, recent work in the Xenopus 
extract system suggests that changes in nucleus size may be attributable to regulated changes in the cytoplasmic 
melieu during early development, independent of cell size15,16. However, the relative contribution of a putative 
cell-size-sensing mechanism and the influence of developmental stage is difficult to assess in most model systems.
Here we use various strategies, including micromanipulation approaches designed to uncouple cell size from 
developmental stage, to investigate the relative contribution of cell size and developmental stage in nuclear size 
control in early embryos. Our data suggest that both mechanisms operate, and we propose a cooperative model in 
which nuclear size is set by a developmental program, and fine-tuned at any given developmental stage according 
to cell size.
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Results
Nuclear scaling during early embryo development. The mouse preimplantation embryo undergoes 
a series of reductive cell divisions without intervening cell growth over the course of ~4 days, progressing first 
to a 16–32 cell morula stage, followed by a 64–128 cell stage blastocyst stage. We first developed methods for 
accurately calculating nucleus and cell volume during preimplantation development in live and fixed embryos 
from 3D confocal z-stack images (Fig. 1A, Fig. S1). By examining embryos of each developmental stage we found 
that nucleus volume decreases ten-fold over the course of preimplantation development, from 8.24 ±  0.19 pL for 
the male pronucleus in 1-cell stage embryos, to 0.69 ± 0.02 pL for nuclei in blastocysts (Fig. 1B). Therefore, as 
expected, nucleus size progressively scales down during preimplantation development in mouse.
To begin to understand the mechanisms of nuclear downscaling, we calculated cell volume for each blasto-
mere in embryos during each stage of preimplantation development (Fig. 1, Fig. S1). This allowed us to directly 
determine the relationship between nucleus size and cell size (N/C ratio) in individual cells within multiple 
embryos. Analysis of this relationship throughout preimplantation development uncovered two noteworthy fea-
tures. First, at any given developmental stage there was a tight correlation between nucleus size and cell size, such 
that N/C ratio was highly consistent between different blastomeres of the same stage (Fig. 1C; Pearsons R2 at 8-cell 
stage = 0.81). This alludes that nuclear size in embryos might depend upon cell size. Second, the value of the N/C 
ratio increased progressively during development, such that the nucleus occupied a greater proportion of cell 
volume in later stage embryos (Fig. 1D). This suggests that cell size is not the only determinant of nucleus size, but 
that there might also be a developmentally-regulated component of nuclear downscaling.
Blastocyst formation marks the formation of the first two cell lineages; the inner cell mass (ICM) and the 
trophoectoderm (TE). To determine whether there is any influence of cell lineage upon nucleus size, we labelled 
blastocysts with OCT4 antibodies, which specifically label ICM cells, to compare N/C ratio in the two cell types 
(±OCT4 labelling). In preliminary experiments we found it difficult to reliably measure volumes in the flattened 
outer cells of the blastocyst. We therefore treated embryos with Ca2+-free media (~10 secs) prior to embryo fixation 
Figure 1. Nuclear volume and N/C ratio during early embryo development. (A) Representative images 
of embryos used to measure volume. (B) Quantification of nucleus size, related to cell; size, on a cell by cell 
basis. Each data point represents an individual cell, colour codes reflect developmental stage. (C) ‘Zoomed’ 
representation of 8-cell embryo data. (D) Data expressed as mean nuclear/cytoplasmic ratio. Note that the N/C 
ratio progressively increases through preimplantation development. 12, 28, 48, 86, 88 and 82 nuclei analysed at 
1,2,4,8-cell, morula and blastocyst stage respectively, over the course of 2 replicates.
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to loosen cell adherence and thus cause cell rounding, and ICM cells were identified with OCT4 antibodies. 
Comparison of ICM and TE revealed no difference in nuclear size between ICM and TE cells (Fig. 2).
Thus in summary, our analysis of N/C ratio across early development alludes to roles for cell size and devel-
opmental stage in nucleus size downscaling, in a manner independent upon cell lineage up to blastocyst stage 
(~64–128 cells).
Evidence that cell size influences nuclear volume in embryos. We next set out to design experi-
ments to directly test the relative influence of cell size and developmental stage upon nucleus size during early 
development.
First, to determine directly whether cell size influences nuclear volume we used micromanipulation to 
experimentally reduce cytoplasmic volume. Removal of 20–40% of cell volume using a micropipette from 
interphase-stage blastomeres had no effect upon nuclear size in the short term (Fig. S2; P = 0.61). We won-
dered however whether reduced cell size might affect the size of a newly forming nucleus at the end of mito-
sis. Therefore, cytoplasm-reduced 2-cell embryos were allowed to divide, and nucleus size was measured in the 
resulting 4-cell stage embryos. Cytoplasmic reduction significantly reduced the size of the nucleus in the resulting 
4-cell embryos from 3.29 ± 0.06 pL to 2.52 ± 0.04 pL, (P = 2.5 × 10−19). To examine the sensitivity of this effect 
we created 4-cell stage embryos of various sizes. Strikingly, nucleus size was tightly correlated with the amount 
of cytoplasm removed, the nucleus size decreasing correspondingly with cell size over a 2–3 fold change in cell 
size (Fig. 3). Therefore, reduction of cytoplasmic volume in interphase leads to smaller nuclei following nuclear 
envelope reformation (NER) at the subsequent mitosis. We note that the relationship between nucleus and cell 
size is not strictly proportional, since a straight line of best-fit would not cross the origin, suggesting a small 
cell-size-independent component of nucleus size control. Nonetheless, taken together with the close correla-
tion observed between nucleus and cell size at any given developmental stage (Fig. 1B), we conclude that cell 
size exerts a major influence upon nuclear size establishment in preimplantation mouse embryos, ensuring that 
within any given developmental stage the larger cells tend to have larger nuclei.
Figure 2. Nuclear downscaling occurs independently of the first cell fate decision. Cells were treated with 
nominally Ca2+-free media for < 10 seconds to cause inter-cellular adherence to be partially lost, causing cells 
to round. Embryos were then fixed and nuclear volume and N/C ratio analysed in Oct4-positive cells, using the 
same methods as previously. Five cells of each cell type were analysed in 10 blastocysts, across two experimental 
days.
Figure 3. Experimental cytoplasmic reduction to probe the role of cell size in nucleus-size setting.  
(A) Experimental design. (B) Examples of control and cytoplasm-reduced embryos fixed and labelled at 4-cell 
stage. (C) Analysis of nuclear and cell volume in the resulting 4-cell embryos. Each point represents one cell. 
Red manipulated, white controls. Note the tight relationship between cell and nuclear size. R2 = 0.67. Data from 
82 nuclei over 4 replicates.
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Evidence that N/C ratio is developmentally regulated in mouse embryos. Next we set out 
to determine whether some aspect of developmental stage aside from cell size might contribute to nucleus 
downscaling. We reasoned that if there were a developmental component to nuclear size control, then nuclear 
downscaling should occur even in the absence of a cell size decrease. To test this, we performed two series of 
experiments. First, we generated binucleated embryos in which pairs of 4-cell stage nuclei were encapsulated 
within cells of 2-cell size (Fig. 4A). Nuclei in binucleated cells had a volume of 3.43 ± 0.10 pL, similar to that from 
normal 4-cell stage embryos (3.27 ± 0.05 pL, P = 0.17), suggesting nuclear downscaling occurs even though there 
was no reduction in cell size. A possible limitation of this experiment is that the impact of neighboring nuclei is 
unclear12,14. Therefore, as a second approach, we produced binucleated 2-cell embryos as previously, and removed 
one nucleus from each cell, thereby creating embryos in which individual nuclei resided in blastomeres twice the 
appropriate size. These embryos were allowed to divide, producing blastomeres possessing 8-cell-stage nuclei 
within ‘4-cell-sized’ cells (Fig. 4B). Nuclei in double-sized blastomeres were the same size (2.36 ± 0.06 pL) as 
similarly-staged non-manipulated 8-cell stage counterparts (2.24 ± 0.05 pL, P = 0.17). Thus, the nucleus scales 
down according to developmental stage even in the absence of the cell-size reduction that normally happens 
during development.
In summary our experiments describe two experimentally distinguishable influences upon nucleus size in 
embryos. First, a cell-size sensing mechanism that works within any given developmental stage to ensure that 
larger cells have larger nuclei. Second, a developmental program that reduces nucleus size at subsequent mitoses, 
and is capable of doing so even if the normal cell-size reduction is prevented.
Nuclear import rates are similar in 2-cell, 4-cell, and 8-cell stage embryos. We next wanted to fur-
ther understand the developmental component of nuclear downscaling. In Xenopus extracts nuclear import rate 
has recently been linked to nuclear downscaling. Specifically, decreasing import rates during the early divisions 
in Xenoups correlate with progressively decreasing nucleus size15. To examine the importance of nuclear import 
in nuclear scaling in embryos we first microinjected two-cell-stage embryos with wheat germ agglutinin (WGA) 
which inhibits nuclear transport17. As expected, microinjection of WGA (0.05 mg/ml estimated final concentra-
tion) dramatically reduced the size of the nucleus following the subsequent mitosis (Fig. S3). Although WGA can 
have off target effects, the concentration used had no other impacts upon development to 4 cell stage apart from 
nucleus size. Thus this experiment confirms the expected result that import participates in establishing nuclear 
geometry (Fig. S3). To determine whether there are changes in nuclear import rate during early development that 
might contribute to nuclear downscaling, we performed Fluorescence Recovery After Photobleaching (FRAP) 
of a GFP-tagged nuclear localization sequence (NLS:GFP)18. We found no difference in fluorescence recovery 
rates between 2-cell, 4-cell and 8-cell embryos (mean recovery in the first minute; 0.107, 0.089 and 0.096 a.u. 
Figure 4. Evidence that N/C ratio is developmentally regulated in mouse. (A) Analysis of nucleus size in 
binucleated embryos. Experimental plan is shown to the left, and an example of a binucleated embryo in the 
centre panel. Data to the right compares nucleus size in binucleated embryos with normal 4-cell controls. 40 
control and binucleated embryos each were examined over 2 days. (B) Analysis of nucleus size in ‘double-
sized’ blastomeres. Note that the resulting 8-cell-stage nuclei in ’double sized’ blastomeres (n = 42) have nuclei 
the same size as control 8-cell embryos (n = 56), which are substantially smaller than control 4-cell embryos 
(n = 40). Data collected over 3 replicates. Different letters indicate P < 0.01 ANOVA (actual values stated in the 
main text).
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respectively; P = 0.80; Fig. 5A, Fig. S4). Thus, in notable contrast to the Xenopus extract system, we found no clear 
evidence of a correlation between nuclear import rate and nucleus size in early mouse embryos.
PKC inhibitors and activators reciprocally affect nucleus size. Recent work in Xenopus embryo 
extracts implicated protein kinase C (PKC) activity in nuclear size regulation. Specifically, it was found that phar-
macological inhibition or hyperactivation of PKC led to reciprocal effects upon nucleus size16. In mouse, intrigu-
ingly, a previous detailed analysis found that the abundance of several PKC isotypes decreases progressively during 
preimplantation development19. We therefore wondered whether the PKC decrease may drive nucleus downscal-
ing, and reasoned that increasing PKC activity in embryos should increase nuclear size, whereas inhibition should 
cause smaller nuclei. To test this we treated embryos with a PKC activator (PMA; 1 ng/ml), or an inhibitor selec-
tive for conventional PKC (Chelerythrine; Chel, 1 μ M). In contrast to Xenopus extracts, where similar treatments 
acutely impact nuclear size, we saw no change in nucleus size over several hours of imaging in interphase (Fig. 5B). 
However, PMA and Chel had striking reciprocal effects on nucleus size following mitosis (Fig. 5C). PKC inhibi-
tion by Chel caused a significant decrease in nuclear size (2.85 ± 0.05 pL) compared to controls (3.23 ± 0.05 pL, 
P = 3.14 × 10−6), whereas PKC activation by PMA caused a significant increase in nuclear volume (4.65 ± 0.17 pL, 
P = 2.14 × 10−12). Similar reciprocal results were obtained with at the 4–8 cell transition (Fig. 5C). Thus treatment 
to increase PKC activity promotes larger nuclei at NER, whereas PKC inhibition promotes smaller nuclei, suggest-
ing the decreasing PKC levels in embryogenesis may contribute to nuclear downscaling.
Figure 5. Evidence that PKC, but not nuclear import, contributes to nucleus size-setting. (A) NLS::GFP 
FRAP in 2-cell, 4-cell, and 8-cell stage embryos (n = 10, 9, 9 respectively from 3 replicates). Note there is no 
difference in the rate of recovery between developmental stages. (B) Live imaging of CAAX::GFP and H2B::RFP 
expressing embryos after interphase addition of PMA or chelyrethrine. (Chel, n = 20, PMA, n = 14 from 2 
replicates) (C) Analysis of the effect of PMA or chel upon nucleus size following NER. A cartoon is shown of 
the experimental design, and images show typical examples of each treatment. Note that the treatments cause 
reciprocal changes in nucleus size. A minimum 37 measurements per experimental group from three replicates. 
All groups are significantly different to each other within a given developmental stage (P < 0.01 ANOVA for 
each comparison, actual values stated in main text).
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Discussion
How nuclear size is determined remains poorly understood in any system, and poses an interesting mechanistic 
puzzle during the reductive divisions of early development. Recent studies predominantly in yeast had extended 
the long-known association between cell size and nucleus size, implying a mechanistic link8,9,11–14. Studies in 
the Xenopus Extract system, on the other hand, highlight the possibility of a role of cytoplasmic contribution 
that was linked to developmental stage15,16. Whilst these two mechanisms are in no way mutually exclusive, the 
huge interspecies differences in cell cycle mechanisms in these settings makes relating these studies difficult, and 
mechanistic examinations of nucleus-size determination in a mammalian system are few. We set out to examine 
the role of these two putative systems in mouse embryos, a system in which cells halve in size each cell cycle, 
whilst the embryo can easily be observed and manipulated ex vivo. Using classical micromanipulation techniques 
to alter cell size, our data show that cell size and developmental stage are two experimentally dissociable factors 
that together regulate the nucleus during this process. We envisage that the two mechanisms are independent but 
co-operate; we propose that gross nucleus size is determined by developmentally regulated cytoplasmic factors 
that drive nucleus downscaling successive mitoses, and is then fine-tuned by a cell-size sensing mechanism that 
ensures that within any developmental stage larger cells tend to have larger nuclei.
Clues as to the molecular identity of the cell-size sensing mechanism remain few1,2,13. A recent study identified 
a dynein-dependent accumulation of membranes at microtubule minus ends adjacent to forming nuclei, that 
serves as a sensor of the peri-nuclear space12. It seems unlikely that the same mechanism should operate in early 
mouse embryos however, since microtubules are apparently randomly oriented20. Given that in mouse embryos 
nuclei rapidly assume a steady-state diameter that remains stable for the majority of interphase, an appealingly 
simple explanation is that an as-yet undetermined limiting factor, that contributes to nuclear structure, distributes 
evenly in the cytoplasm in mitosis, presenting the larger blastomere with more substrate21.
More clues are available regarding the developmental shift in nucleus size. Whereas we were unable to find 
evidence of a developmental regulation in nuclear import, our experiments suggest that PKC activity contributes. 
This notion is supported by reciprocal effects of PKC activators and inhibitors on nuclear size establishment, both 
at 4 cell and 8 cell stage, which correspond with the decrease in PKCs previously described in mouse embryos19. 
Although it is important to note that there are clearly species differences in this mechanism between Xenopus 
and mouse, since PKC activity and nucleus size are inversely correlated in Xenopus Extracts16, our data suggest 
a conserved role for PKC in early developmental nucleus size determination. Though reciprocal PKC activator 
and inhibitor effects are strong evidence of PKCs involvement, future genetic studies are certainly warranted to 
further detail this involvement, and ascertain which isoforms are most implicated. Moreover, how PKC activity 
contributes to nuclear size control in embryos remains to be determined. Intriguingly, relative expression of lamin 
isotypes changes dramatically during early development22 (see also Fig. S5). Since lamins are PKC substrates, 
we speculate that that PKC activities may modulate lamin incorporation, and that dynamic lamin expression 
levels and phosphorylation states may thus together impact nuclear size during development. Whereas a simple 
limiting-factor hypothesis is appealing in terms of controlling nucleus size between cells of the same develop-
mental stage (discussed above), the idea that the availability of a nuclear envelope component (such as a lamin 
isoform) might be responsible for the overall downscaling that takes place during development appears unlikely, 
since total nuclear surface area per embryo increases dramatically during the reductive divisions of early embry-
ogenesis (Fig. S6). Finally, it is noteworthy that in mouse the 1-cell embryo possesses two nuclei of highly distinct 
sizes (see Fig. 1). Since it is hard to imagine that cytoplasmic space or availability of a substrate should limit the 
growth of only one nucleus, a role for the chromatin state in differential nuclear size setting in embryos is also 
possible23,24. Whether chromatin modifications contribute to nuclear downscaling remains to be addressed.
Given the fundamental importance and conceptual simplicity of organelle size-setting and homeostasis, it is 
remarkable how poorly understood these mechanisms remain. Here we have shown that nucleus size regulation 
during preimplantation development is unlikely a single pathway, but comprises at least two mechanistically dis-
tinguishable functionalities. Our experiments provide one of the first indications of how the embryo goes about 
the task of adjusting cellular architecture in the face of extreme changes in cell size, and underlines the utility of 
the mouse embryo as a tool for further dissection of organelle-cell size relationships in dividing and differentiat-
ing cells.
Methods
Embryo handling, microinjection and micromanipulation. Embryos were obtained from MF1 mice, 
and embryo culture and microinjection performed as previously25,26. Enucleation and cytoplasmic removal were 
performed in media containing 10 μ g/ml cytochalasin using an enucleation pipette, and piezo unit (PrimeTech) 
to breach the zona. Experiments approved by UK Home Office and performed under a PPL to GF. All experi-
ments were in accordance with UK home office guidelines.
Immunofluorescence and fluorescent proteins. Embryos were fixed for 30 mins in 4% Paraformaldehyde, 
permeabilised for 10 mins in 0.25% Triton X-100 at 25 °C, and blocked in PBS containing 3% BSA for one hour at 
37 °C. Labels used: Alexa Fluor-546 Phalloidin (LifeTech; 1:1000), Hoechst 33342 (LifeTech; 1:1000) or DRAQ5 
(LifeTech; 1:300). Primary antibodies used: Oct4 (Santa Cruz 1:300), Lamin A (Abcam; ab2630, 1:200) Lamin 
B1 (Abcam; ab16048, 1:1000) Lamin B2 (Abcam; ab151735, 1:250) Alexa-fluor secondary antibodies (Life 
Technologies) were used as appropriate. Blastocysts were subjected to nominally Ca2+-free media to cause partial 
cellular rounding to facilitate volume measurements. Plasmids used were: NLS:GFP in pHM840 (from Addgene), 
CAAX:GFP pcDNA3.1 (from Guillaume Charras), H2B:RFP in pRN4 (from Alex McDougall). Polyadenylated 
cRNA was manufactured using mMessage mMachine Ultra (Ambion), as previously25.
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Imaging and data analysis. Confocal images were obtained using a Zeiss LSM 510. All live imaging exper-
iments were performed in KSOM at 37 °C/5% CO2. For FRAP, photobleaching was performed with 100% 488-nm 
laser for 20 iterations. Nuclear import rate is expressed as nuclear divided by cytoplasmic fluorescence (both 
background subtracted), normalised to a prebleach value of 1. For measuring volumes, the N/C ratio of each blas-
tomere was calculated by tracing plasmalemma and nuclear outlines in every z-slice at 2 μ m z-intervals. Unless 
otherwise noted all data were confirmed on at least 3 experimental days. Image analysis was performed using 
Image J/Fiji. Error bars are s.e.m. Where used, ANOVA was performed using Graphpad, and Students T-tests 
were used using Excel.
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